Advertisement
Screener

Gyre Therapeutics, Inc. (GYRE) Material Contracts

Gyre Therapeutics, Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-05-04: Form 8-K; Exhibit 10.5; Description Amended and Restated Cullgen Inc. 2018 Stock Incentive Plan..
  • 2026-03-02: Form 8-K; Exhibit 10.4; Description Form of Lock-Up Agreement.
  • 2026-03-02: Form 8-K; Exhibit 10.3; Description Form of Registration Rights Agreement.
  • 2026-03-02: Form 8-K; Exhibit 10.2; Description Form of Company Support Agreement.
FiledFormExhibitDescription
2026-05-048-K10.5Amended and Restated Cullgen Inc. 2018 Stock Incentive Plan.
2026-03-028-K10.4Form of Lock-Up Agreement
2026-03-028-K10.3Form of Registration Rights Agreement
2026-03-028-K10.2Form of Company Support Agreement
2026-03-028-K10.1Form of Cullgen Support Agreement

Similar stocks

Stock NameCountryMarket CapPE Ratio
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
GERON CORP (GERN)United States$0.803B-12.14
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78